CHU Saint Eloi; Service d'Hématologie Clinique

Montpellier 34295

0 studies enrolling now · 1 studies all time

What they study most

Lymphoma

Studies at this site

• A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma — Completed